Bellosillo, Beatriz
Montagut, Clara
Article History
First Online: 25 November 2019
Competing interests
: B.B. has received honoraria for a speaker, consultancy or advisory role from Astra-Zeneca, Biocartis, Merck Serono, Novartis, Qiagen, Hoffman–La Roche, ThermoFisher, Pfizer and Bristol-Myers Squibb. C.M. declares institutional research funding from Amgen, Bayer, Biocartis, BMS, Merck Serono, Roche, and Sanofi Aventis as well as advisory board or speaker fees from Amgen, Biocartis, Merck Serono, Roche, Symphogen, Guardant Health, Seattle Genetics and Sysmex.